Zvláštní léčebný program – tamoxifen

This document concerns a special treatment program focused on tamoxifen. It was published on August 4, 2026, by the Department of Drug Availability. The program includes a list of unregistered medicinal products from which individually prepared medicinal products (IPLP) can be prepared. The list contains information such as the name of the unregistered drug, its strength, dosage form, package size, and number of blisters. It also includes data on the batch, expiry date, number of packages, excipients, and distributor. An information document for patients about tamoxifen is also available in PDF format, with a size of 262 kB.